M13 Laquinimod Reduces Hyper-reactive Pro-inflammatory Cytokine Release From Human Primary Huntington’s Disease Myeloid Cells

L Dobson; U Träger; L Hayardeny; SJ Tabrizi

doi:10.1136/jnnp-2014-309032.285

Article info

Experimental therapeutics – preclinical

M13 Laquinimod Reduces Hyper-reactive Pro-inflammatory Cytokine Release From Human Primary Huntington’s Disease Myeloid Cells

Authors

L Dobson 1Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London, UK PubMed articles Google scholar articles
U Träger 1Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London, UK PubMed articles Google scholar articles
L Hayardeny 2Teva Pharmaceutical Industries Ltd., Israel PubMed articles Google scholar articles
SJ Tabrizi 1Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London, UK PubMed articles Google scholar articles

Citation

Dobson L, Träger U, Hayardeny L, et al

M13 Laquinimod Reduces Hyper-reactive Pro-inflammatory Cytokine Release From Human Primary Huntington’s Disease Myeloid Cells

Journal of Neurology, Neurosurgery & Psychiatry 2014;85:A98-A99.

Publication history

First published September 17, 2014.

Online issue publication

April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password